Table 3 Potential annual cost-savings for reduced adverse events for colorectal cancer surgery by surgical caseload (AU$ 2009)
% reduction in adverse events | No. cases | Mean cost-saving $ | (95% CI) $ |
|---|---|---|---|
50% (baseline) | 1 | 2,436 | 904 - 4,463 |
| Â | 20 | 48,720 | 18,080 - 89,260 |
| Â | 40 | 97,440 | 36,160 - 178,520 |
| Â | 70 | 170,520 | 63,280 - 312,410 |
25% (small effect) | 1 | 1,248 | 99 - 3,149 |
| Â | 20 | 24,960 | 1,980 - 62,980 |
| Â | 40 | 49,920 | 3,960 - 125,960 |
| Â | 70 | 87,360 | 6,930 - 220,430 |
75% (large effect) | 1 | 3,636 | 1,580 - 6,047 |
| Â | 20 | 72,720 | 31,600 - 120,940 |
| Â | 40 | 145,440 | 63,200 - 241,880 |
| Â | 70 | 254,520 | 110,600 - 423,290 |